Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial | The BMJ

Posted byketaminhPosted inEmergency medicine and critical care, FOAMEd, ketamine, mental-healthTags:

Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial | The BMJ
— Read on www.bmj.com/content/376/bmj-2021-067194

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

%d bloggers like this: